Santa Barbara Independent3d
Dr. Jennifer Doudna Talks Editing Genes and Shredding Cancer
UCSB Arts & Lectures and the Cancer Foundation of Santa Barbara host the Nobel Prize–winning biochemist for a talk on CRISPR ...
The New Yorker9d
Jennifer Doudna on the Brave New World Being Ushered In by Gene Editing
The technology’s promise can sound like science fiction—it might help us adapt to a radically different climate, or grow ...
C&EN11dOpinion
Editorial: Gene editing is an opportunity for chemistry’s good governance
In March 2023, the Organising Committee of the Third International Summit on Human Genome Editing published a statement ...
With AI warning, Nobel winner joins ranks of laureates who’ve cautioned about the risks of their own work
When computer scientist Geoffrey Hinton won the Nobel Prize for his work on machine learning, he immediately issued a warning ...
Buy Rating for Editas Medicine: Promising In Vivo CRISPR Platform and Strategic Growth Potential Amid Speculative Investment
Editas Medicine (EDIT – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Jack Allen ...
Promising Financial Position and Advancements Propel Editas Medicine to a ‘Buy’ Rating
JonesTrading analyst Soumit Roy has assigned their bullish stance on EDIT stock, giving a Buy rating today. Soumit Roy’s rating is based ...
WLWT10d
With AI warning, Nobel winner joins ranks of laureates who’ve cautioned about the risks of their own work
"2020: Gene editingFour years ago, Jennifer Doudna and Emmanuelle Charpentier shared the Nobel Prize in chemistry for the development of a method for genome editing called CRISPR-Cas9. In her ...